Nechanitzky, Robert
Ramachandran, Parameswaran
Nechanitzky, Duygu
Li, Wanda Y.
Wakeham, Andrew C.
Haight, Jillian
Saunders, Mary E.
Epelman, Slava http://orcid.org/0000-0003-3400-4475
Mak, Tak W. http://orcid.org/0000-0001-6766-861X
Funding for this research was provided by:
Gouvernement du Canada | Instituts de Recherche en Santé du Canada | CIHR Skin Research Training Centre
Article History
Received: 16 May 2023
Revised: 15 January 2024
Accepted: 7 February 2024
First Online: 21 February 2024
Competing interests
: The authors declare that they have no competing financial interests concerning the work described in this manuscript. TWM owns equity in Treadwell Therapeutics and Agios Pharmaceuticals, and is a consultant for AstraZeneca and Tessa Therapeutics.
: The Ontario Cancer Institute Animal Care Committee approved all animal research and mouse experiments used in this study.